Registration Options

Activity Dates: 04/17/2023 - 04/17/2026

AAPP 2023 registration is closed.

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Approximately 70 million Americans experience chronic sleep problems. Sleep disorders have become even more prevalent with COVID-19, not only due to the infection, but also because of quarantine, isolation, financial loss, and increased anxiety and stress. The sequela from this can be vast including exacerbation of other mental health or medical conditions, increased injuries, lost work productivity, and reduced quality of life. As a result, several new medications for sleep disorders were approved over the past few years. Lack of familiarity with newer medications or exposure to patients with sleep disorders may limit a clinician’s comfort with recommending, prescribing, and counseling on these medications. However, a pharmacist’s expertise in dosing, mechanism of action, drug interactions, concerns with comorbid conditions, and adverse effects is necessary for safe prescribing. Psychiatric pharmacists are in a key role to help identify individuals who may be appropriate for drug therapy and optimize safe and appropriate treatment options for a patient’s sleep disorder regardless of their area of practice. This session is designed to provide education on new and emerging treatment options for the management of sleep disorders.

Published Research Related to this Session: 
  • McCarthy C, McGrane I. Sleep-Wake Disorders [Chapter]. Ambulatory Care Pharmacotherapy Self-Assessment Program, 2022: Neurologic Care and Pain Management. Lenexa, KS: American College of Clinical Pharmacy. [Release date: November 2022]
  • McGrane I, Lister J. Sleep-Wake Disorders [Chapter]. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2021 Book 2. Neurology and Psychiatry. Lenexa, KS: American College of Clinical Pharmacy, 2021:63-84. 26.
  • McGrane IR, Leung JG, St. Louis EK, Boeve BF. Melatonin Therapy for REM Sleep Behavior Disorder: A Critical Review of Evidence. Sleep Med 2015;16(1):19-26.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Ian McGrane, PharmD, BCPS, BCPP

View biographical information and disclosures

Learning Objectives

  1. Compare newer medications for management of sleep disorders to those commonly prescribed in clinical practice.
  2. Assess the role of new and emerging medications in the treatment of sleep disorders.
  3. Formulate a treatment plan for the management of sleep disorders using new and emerging medications.

Continuing Education Credit and Disclosures

Activity Dates: 04/17/2023 - 04/17/2026
ACPE Contact Hours: 1
ACPE Number: 0284-0000-23-006-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.